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Development of CS-TPP-dsRNA
nanoparticles to enhance RNAi
efficiency in the yellow fever
mosquito, Aedes aegypti
Ramesh Kumar Dhandapani, Dhandapani Gurusamy, Jeffrey L. Howell

& Subba Reddy Palli

Mosquito-borne diseases are a major threat to human health and are responsible for millions of deaths
globally each year. Vector control is one of the most important approaches used in reducing the
incidence of these diseases. However, increasing mosquito resistance to chemical insecticides presents
challenges to this approach. Therefore, new strategies are necessary to develop the next generation
vector control methods. Because of the target specificity of dsRNA, RNAi-based control measures
are an attractive alternative to current insecticides used to control disease vectors. In this study,
Chitosan (CS) was cross-linked to sodium tripolyphosphate (TPP) to produce nano-sized polyelectrolyte
complexes with dsRNA. CS-TPP-dsRNA nanoparticles were prepared by ionic gelation method. The
encapsulation efficiency, protection of dsRNA from nucleases, cellular uptake, in vivo biodistribution,
larval mortality and gene knockdown efficiency of CS-TPP-dsRNA nanoparticles were determined. The
results showed that at a 5:1 weight ratio of CS-TPP to dsRNA, nanoparticles of less than 200 nm mean
diameter and a positive surface charge were formed. Confocal microscopy revealed the distribution of
the fed CS-TPP-dsRNA nanoparticles in midgut, fat body and epidermis of yellow fever mosquito, Aedes
aegypti larvae. Bioassays showed significant mortality of larvae fed on CS-TPP-dsRNA nanoparticles.
These assays also showed knockdown of a target gene in CS-TPP-dsRNA nanoparticle fed larvae. These
data suggest that CS-TPP nanoparticles may be used for delivery of dsRNA to mosquito larvae.
Mosquitoes affect human health by transmitting deadly diseases such as malaria, Chikungunya, dengue, and
yellow fever. These mosquito-borne pathogens negatively affect millions of people each year, and the burden of
diseases transmitted by mosquitoes on human health has been well documented1. Vector control is a crucial strategy to mitigate transmission and reduce the prevalence of vector-borne diseases. Conventional methods for adult
mosquito control include repellents, insecticidal sprays, and insecticide-treated nets. Management of larvae is
typically limited to insecticidal treatments and removal of standing water sources in areas where mosquito populations are abundant. However, the efficacy of these methods has been decreasing over time due to the widespread
development of resistance by mosquitoes to chemical insecticides and growing environmental concerns of residual toxicity2. In this context, RNA interference (RNAi), a sequence-specific, post-transcriptional gene silencing
method that is triggered by the introduction of double-stranded RNA (dsRNA) may help3. RNAi technology has
emerged not only as a powerful tool for functional genomics studies but also as a potentially useful method for
controlling insect pests and disease vectors because of its target specificity. Although RNAi is a highly conserved
mechanism in eukaryotes including fungi, plants, insects, and mammals4–9, there are still hurdles for successful
implementation of RNAi to knockdown genes in many species of insects10. Lack of suitable delivery methods for
dsRNA and variability in cellular uptake and transport of dsRNA in insects are the significant challenges in gene
silencing efforts. Additionally, dsRNA must overcome specific obstacles such as poor cellular internalization,
rapid degradation by nucleases, and limited blood stability11. Another limitation for successful RNAi in insects
is the lack of conserved dsRNA transporter genes, resulting in a poor systemic RNAi response12. Also, dsRNA is
prone to degradation by nucleases in the body of the insect13. Therefore, developing a safe and effective dsRNA
carrier system for delivery into target cells of the cytoplasm is critical in order to investigate its potential application for control of insect pests and disease vectors.
Department of Entomology, University of Kentucky, Lexington, Kentucky, 40546, USA. Correspondence and
requests for materials should be addressed to S.R.P. (email: rpalli@email.uky.edu)
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Among the vectors that have been studied for delivery of genes into cells, viral vectors have demonstrated high
transfection efficiency in most cells studied. However, non-viral vectors are much more attractive due to their
ease of synthesis, low immune response against the vector, unrestricted load carrying capacity and safety14. A
chitosan-based carrier system is one example of a non-viral vector that has gained interest in recent years as a safe
and economical delivery system for dsRNA, siRNA, plasmid DNA (pDNA), oligonucleotides (ODN), peptides
and even proteins. CS has beneficial properties such as low toxicity, low immunogenicity, and excellent biodegradability as well as a high positive charge that helps to form polyelectrolyte complexes with negatively charged
nucleic acids by electrostatic interaction15–19. CS-based nanoparticles have been successfully used for delivery of
dsRNA in mosquitoes20–22. However, the knockdown efficiency achieved by CS conjugated dsRNAs is not very
high. Therefore, there is a need to improve CS nanoparticles for efficient delivery of dsRNA. Cross-linkers such
as sodium tripolyphosphate (STPP) could play an important role in stabilizing CS nanoparticles. Sodium tripolyphosphate (STPP) is a suitable cross-linker due to its small size, anionic charge, low toxicity and quick gelling
ability23. A CS-siRNA complex can be formulated through several cross-linkers, such as TPP, dextran sulfate,
and poly-D-glutamic acid using ionic gelation methodology. Due to its small size, high rate of entrapment and
binding affinity, CS-TPP nanoparticles are ideal for siRNA delivery. Indeed, serum stability assays exhibit higher
siRNA protection when CS-TPP nanoparticles were used24. CS-TPP nanoparticles were shown as better vehicles
of siRNA delivery when compared to CS-siRNA complexes, and this complex was easily taken up by cells25. Thus,
CS-TPP-dsRNA can be used for gene delivery into cells. In this study, positively charged CS-TPP-dsRNA nanoparticles were prepared to deliver dsRNA to induce RNAi in the yellow fever mosquito, Aedes aegypti.

Results and Discussion

Synthesis of CS-TPP-dsRNA nanoparticles. The CS-TPP-dsRNA nanoparticles were prepared by ionic
gelation method by cross-linking the negatively charged phosphate groups of TPP with the positively charged
amino groups of CS. Visual inspection of CS-TPP-dsRNA solution showed a clear solution when TPP concentration is low (0.25-0.75 mg/ml), opalescent suspension when TPP concentration is medium to high (0.75–1.5 mg/
ml) and spontaneous aggregation under high TPP (1.25–1.5 mg/ml) and low CS (1 mg/ml) concentrations
(Table S1). These results suggest that the formation of suitable nanoparticles only occurs at specific concentrations of CS and TPP26–28.
The nanoparticles were prepared by ionic interaction using different ratios (1:1, 3:1, 5:1 and 7:1) of CS-TPP.
During the synthesis of nanoparticles, the ratio of CS-TPP was adjusted to synthesize smaller size and positively
charged particles to facilitate their interaction with cell membranes. The size, charge, and PDI measured by DLS
are listed in Table S2. The charge of CS-TPP nanoparticles increased with an increase in CS concentration. The
size of the particles increased from CS-TPP ratio of 1:1 to 7:1 except at a ratio of 5:1 where the particle size was
lower than those formed by all other ratios tested. The CS-TPP ratio of 5:1 which formed smaller particles with
a positive charge were selected for further development. CS-TPP-dsRNA nanoparticles were prepared by ionotropic gelation method previously described for the development of siRNA, protein, peptides, and drug molecule
nanoparticles29–33. CS-TPP-dsRNA nanoparticles were prepared using 250 µg of dsRNA, 1 mg TPP and 1–7 mg CS
and characterized by DLS. The CS-TPP-dsRNA nanoparticles formed by increasing concentration of CS (1–7 mg)
showed an increase in size except at 5 mg CS where lower size particles were detected (Table S3). The charge of
the nanoparticles also increased with an increase in the concentration of CS. The incorporation of dsRNA into
CS-TPP-dsRNA nanoparticles increased with an increase in the concentration of CS from 1–5 mg but decreased
at 7 mg CS (Table S3). The CS-TPP-dsRNA nanoparticles were analyzed by gel retardation assays. As shown in
Fig. S1, the dsRNA did not form complexes with CS-TPP at 1:1 ratio of CS-TPP. In contrast, at CS-TPP ratio of
3:1, 5:1 and 7:1 nanoparticles were formed and showed a retarded migration and stayed in the well (Fig. S1). The
results showed that 3:1, 5:1 and 7:1 ratio of CS-TPP induced the formation of complexes with dsRNA. This may
be due to the formation of nanoparticles in a process derived from inter and intramolecular linkages facilitated
by the anionic molecules34. The nanoparticles produced using dsRNA and CS:TPP at 3:1, 5:1 and 7:1 ratio were
tested in Aag-2 mosquito cell line. The nanoparticles produced by CS-TPP 7:1 ratio caused a decrease in the cell
viability and affected cell morphology. This may be due to the strong electrostatic interaction between the cell
membranes and positively charged nanoparticles35. Based on size, charge, absorption, and effect on cell viability,
nanoparticles prepared using a 5:1 ration of CS-TPP and dsRNA were used in subsequent experiments.
Characterization of CS-TPP-dsRNA nanoparticles. Gel retardation assays of the CS-TPP-dsRNA nan-

oparticles prepared showed efficient incorporation of dsRNA into nanoparticles (Fig. 1A). The mean particle
size of CS-TPP-dsRNA is less than 200 nm and a lower PDI of 0.207 as determined by DLS (Fig. 1B). The surface
charge of CS-TPP-dsRNA nanoparticles is +34.37 ± 0.94 mV (Fig. 1C). The TEM images of CS-TPP-dsRNA nanoparticles showed a spherical structure (Fig. 1D,E). The possibility of nanoparticles modifying the surface morphology is of particular importance for in vivo applications. It has previously been reported that particles in the
nanometer size and of the spherical structure have a relatively higher intracellular uptake compared to microparticles36. In our studies, approximately 80% entrapment efficiency was observed as measured by UV-visible spectrophotometry. Previous studies showed that the entrapment efficiency of siRNA loaded onto nanoparticles
decreased significantly by increasing CS concentration. Inefficient siRNA entrapment was noted when higher
concentrations of CS were used as the viscous solution restricted the association of the siRNA37. The low entrapment efficiency of nanoparticles may be due to interference shielding effects, which affect the interaction between
nucleic acid and amino groups of CS38.
One of the most important factors governing RNAi efficiency is the capacity of a carrier system to protect
dsRNA from nuclease degradation. To investigate the nuclease protection ability of CS-TPP-dsRNA nanoparticles, the nanoparticles prepared were exposed to the lumen contents of the alimentary canal dissected from mosquito larvae. The nucleases present in the lumen of mosquito larvae degraded naked dsRNA within one hour of
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Figure 1. Preparation and characterization of CS-TPP-dsRNA nanoparticles. (A) The formation of CS-TPPdsRNA complexes was verified by agarose gel electrophoresis. 1 kb plus ladder, naked dsRNA and CS-TPPdsRNA complexes were resolved on 1% (w/v) agarose gel, stained with GelRed and photographed under UV
light. The picture of the gel shows differences in the migration of free dsRNA and CS-TPP-dsRNA complexes.
(B,C) The mean particle diameter (z-average), polydispersity (PDI), and zeta potential (surface charge) of
freshly prepared CS-TPP-dsRNA nanoparticles were determined by photon correlation spectroscopy (PCS)
using Zetasizer (Malvern Instruments, UK). All measurements were performed in triplicate at 25 °C and
data are represented as mean ± standard deviation. (D,E) Morphological characterization of CS-TPP-dsRNA
nanoparticles was carried out by Transmission electron microscopy. A drop of CS-TPP-dsRNA nanoparticles
on the copper microgrid was natively stained with 2% phosphotungstic acid and photographed under a TEM
(HRTEM, JEOL 2010F, Japan).

®

Figure 2. Stability of CS-TPP-dsRNA nanoparticle complexes exposed to lumen contents of mosquito larvae
was assessed by gel electrophoresis. CS-TPP-dsRNA nanoparticles were exposed to lumen contents collected
from Aedes aegypti larvae. At 1, 3, 6, 12 and 24 h after mixing dsRNA and lumen contents, the samples were
collected and resolved on 1% agarose gels. The gels were stained with GelRed and photographed under UV
light. M, 1Kb plus DNA ladder; A, Naked dsRNA; B, dsRNA dissociated from CS-TPP-dsRNA; C, CS-TPP NP
and L, lumen contents.

®

exposure39. In contrast, the CS-TPP-dsRNA nanoparticles protected dsRNA from nuclease degradation up to 24 h
(Fig. 2). In addition, dsRNA was dissociated from CS-TPP nanoparticles with the help of heparin (1000 U-ml).
The dsRNA stability was analyzed by gel electrophoresis. As shown in Fig. 2, the dsRNA in CS-TPP-dsRNA complexes was protected from digestion by nucleases. The average band intensity in gels was determined and shown
in Fig. S2. The intensity of bands was not significantly different confirming that the dsRNA in CS-TPP-dsRNA
complexes was protected from digestion by nucleases.
CS-TPP-dsRNA nanoparticles were stored at various temperatures of 4 °C, 25 °C and 37 °C in deionized water
up to 10 days and analyzed by gel electrophoresis. As shown in Fig. S3, no reduction in CS-TPP-dsRNA complexes
were detected. A previous study revealed that cross-linkers can enhance the stability of particulates40. We found
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that nanoparticle size increased after 10 days of storage. These results are similar to reports on CS-TPP-siRNA
nanoparticles, which exhibited a slight increase in particle size after 15 days of storage24. The release profile of
dsRNA from CS-TPP was studied in PBS at pH 7.4 up to 60 h. dsRNA was rapidly released during the first 30 h,
which resulted in a 39% cumulative release of dsRNA (Fig. S4). After 30 h, the dsRNA was slowly released up
to 60 h, resulting in a 55% cumulative dsRNA release (Fig. S4). Cross-linking may be responsible for the strong
interaction between CS-TPP-dsRNA nanoparticles.

In vivo biodistribution and internalization of CS-TPP-dsRNA nanoparticles. An overall positive charge of the nanoparticle complex formed under optimal conditions fosters cell attachment, followed by
membrane fusion via endocytosis, and ultimately endosomal escape by proton sponge effect41. We studied in
vivo biodistribution and internalization of nanoparticles in mosquito larvae using FITC-labeled CS-TPP-dsRNA
nanoparticles. At 24 h post feeding, whole larvae examined under a fluorescence microscope showed clear green
signals of FITC-labeled nanoparticles in the whole larval body. The clear fluorescence signals were visualized in
both fat body attached to the epidermis and midgut tissues, whereas no fluorescence signals were observed in
the control tissues (Fig. 3). Confocal microscopy analysis of the tissues dissected from FITC-labeled nanoparticles revealed fluorescence signals representing FITC-labeled nanoparticles internalized in the midgut and fat
body cells (Fig. 4). Conversely, the tissues dissected from FITC-fluorescein fed larvae did not show any such signals (Fig. 4). Previous studies showed that both positively and negatively charged nanoparticles were distributed
throughout the larval body, but positively charged nanoparticles exhibited faster attachment or internalization
in tissues. Indeed, positively charged nanoparticles were present in the gastrointestinal tract within the gastric
caeca. Although negatively charged nanoparticles were detected even after adult metamorphosis in tissues associated with the head, body parts, and ovaries, in vitro studies found that positively charged nanoparticles were
more effective than negatively charged nanoparticles in mosquito larvae42,43. Our data showing the distribution of
positively charged nanoparticles in the midgut, fat body and epidermis are in line with these published reports. In
mammalian cells, positively charged nanoparticles are internalized more efficiently than negatively charged nanoparticles due to their electrostatic interactions with the plasma membrane44. Indeed, positively charged CS-TPP
nanoparticles were shown to deliver nucleic acids into HeLa cells36.
The efficacy of CS-TPP-dsRNA nanoparticles.

The effectiveness of CS-TPP-dsRNA nanoparticles in
silencing target genes and killing mosquito larvae was tested. Nine candidate genes (Table S4) were selected based
on their effectiveness in triggering RNAi in Aedes aegypti and other insects tested. The dsRNA prepared using
fragments of nine selected genes and the gene coding for enhanced green fluorescence protein (EGFP) as a control
were used to prepare CS-TPP-dsRNA nanoparticles. The nanoparticles, mosquito larval food, and agarose were
used to prepare food pellets. The food pellets were fed to larvae once a day until pupation. The mortality caused
by CS-TPP-dsRNA nanoparticles varied from 20–65% depending on the gene targeted. The variation in mortality
caused by CS-TPP-dsRNA nanoparticles targeting different genes may be related to the function of these target
genes. The control larvae fed on CS-TPP-dsGFP showed 18% mortality. The CS-TPP-dsRNA nanoparticles targeting IAP, SNF7, SSK, and OTK caused significantly higher mortality when compared to the mortality caused by
control CS-TPP-dsGFP nanoparticles (Fig. 5). We then compared naked dsIAP, CS-dsIAP and CS-TPP-dsIAP for
their ability to induce mortality in Ae. aegypti larvae. Compared to >60% mortality induced by CS-TPP-dsIAP
nanoparticles, the CS-dsIAP nanoparticles induced only 35% mortality and the naked dsIAP did not induce
significant mortality (Fig. 6). We determined the IAP gene knockdown efficiency using reverse-transcriptase
quantitative real-time PCR (RT-qPCR). The mRNA levels of IAP target gene were quantified on the fifth day after
initiation of feeding naked dsIAP, dsGFP, CS-dsIAP, CS-dsGFP, CS-TPP-dsGFP or CS-TPP-dsIAP. Oral administration of CS-TPP-dsIAP or CS-dsIAP nanoparticles reduced the IAP mRNA levels by 62% and 27% respectively
when compared to the levels in control larvae treated with CS-TPP-dsGFP or CS-dsGFP (Fig. 7). The naked
dsIAP feeding did not cause knockdown on iap gene. These results suggest that feeding mosquito larvae with
CS-TPP-dsRNA nanoparticles can deliver dsRNA to their cells, resulting in uptake of dsRNA and suppression of
target gene expression. The iap gene from Bombyx mori was identified and shown to function as a caspase inhibitor to block apoptosis45. The iap1 gene was identified in Ae. aegypti and showed that the gene product inhibits
both initiator and effector caspases46. In Aag-2 cells, five genes coding for IAPs (1, 2, 5, 6 and 9) were identified.
Treating these cells with dsRNA targeting these genes caused a significant reduction in target gene mRNA levels,
but only dsIAP1 induced apoptosis phenotype47. Knockdown of iap gene caused mortality in Lygus lineolaris
Halyomorpha halys, Agrilus planipennis, and Anoplophora glabripennis48–51.

Conclusions

The previous studies20–22,52 used CS nanoparticles to deliver dsRNA to silence genes in insects, including Ae.
aegypti. However, the knockdown efficiency and mortality achieved by CS-mediated delivery of dsRNA were not
very high; therefore, these nanoparticles are not widely used to deliver dsRNA to mosquitoes and other insects.
In our previous studies in Ae. aegypti larvae, CS nanoparticle-based delivery of dsRNA caused less than 50%
knockdown of the target gene and larval mortality52. In this study, we found that CS-TPP-dsRNA nanoparticles
are better than CS nanoparticles in delivering dsRNA to mosquito larvae. In future studies, it may be possible to
achieve up to 100% mortality of larvae after modifying strong bond interaction of nanoparticles and identifying
an effective target gene. Work is in progress to screen and identify effective target genes and to determine the
best delivery system to achieve 100% mortality of Ae. aegypti larvae after delivery of dsRNA using nanoparticles.
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Figure 3. Fluorescence microscope analysis of the distribution of FITC labeled CS-TPP nanoparticles in
mosquito larvae. CS-TTP-dsRNA nanoparticles labeled with FITC fluorescein dye were fed to mosquito larvae.
At 24 h after feeding of nanoparticles, the midgut and epidermis with the attached fat body were dissected. The
tissues were washed with 1X PBS buffer and then visualized under Nikon ECLIPSE 90i fluorescence microscopy.
White and red arrows indicate fat body (FB) and epidermis (Epi) tissues, respectively. (Scale bar = 50 µm).

Materials and Methods

Visual inspection of CS-TPP nanoparticles formation. The formation of CS-TPP nanoparticles was
examined by visual inspection27,28. A preliminary test was done to determine the optimum conditions required
for the formation of nanoparticles. In this regard, medium molecular weight CS (75–85% deacetylated) was dissolved in 1% acetic acid (w/v) to prepare 10 mg/ml solution. The TPP was dissolved in deionized water (0.25–
1.5 mg/ml). Visualization of the nanoparticle formation was carried out by the addition of 2 ml of TPP solution to
5 ml of CS solution under magnetic stirring at room temperature.
Nanoparticles preparation. CS-TPP-dsRNA nanoparticles were formed using the ionic gelation method.

Nanoparticles were prepared by adding 1 ml of TPP aqueous solution (1 mg/ml) and 1 ml of dsRNA (0.250 mg/
ml) in deionized water in a dropwise manner to 5 ml of CS solution (1 mg/ml) under magnetic mixing at room
temperature. The nanoparticles were then incubated for 30 min at room temperature. Nanoparticles were collected by centrifugation at 13,000 × g for 10 min. The supernatant was removed, and the pellet was washed three
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Figure 4. Confocal microscope analysis of biodistribution of FITC labeled CS-TPP nanoparticles in mosquito
larvae. CS-TPP-dsRNA nanoparticles conjugated with FITC fluorescein dye were fed to mosquito larvae. At
24 h after feeding of nanoparticles, midgut and epidermis with the attached fat body were dissected. The tissues
were washed with 1X PBS buffer and fixed with 4% paraformaldehyde. Tissues were stained with mounting
medium containing DAPI and visualized under 63X magnification of Leica SP8 confocal microscope. The white
and red arrow indicates nucleus and nanoparticles, respectively (Scale bar = 20 µm, Top three panels) and 5 µm,
Bottom panel).

Figure 5. Screening candidate genes to control mosquito larvae by delivering dsRNA conjugated to CS-TPP
nanoparticles. Mosquito larvae were fed on CS-TPP-dsRNA nanoparticles containing dsRNA targeting nine
selected genes or GFP used as a control. Mortality was recorded on the 10th day after initiation of feeding.
Mean ± S.E (n = 3). The asterisks above the bar indicate the significance of difference (One-way ANOVA,
Turkey’s test **P< 0.05, ***P< 0.001). GFP, green fluorescence protein; IAP, an inhibitor of apoptosis; SNF7,
vacuolar-sorting protein; SRC, steroid receptor co-activator; SSK, Snakeskin; HEL25E, Helicase at 25E; MESH,
membrane-spanning protein; LRC, leukocyte receptor complex member; OTK, offtrack and SAC1, suppressor
of actin.
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Figure 6. dsIAP conjugated to CS and CS-TPP nanoparticles induce mortality in mosquito larvae. Mosquito
larvae were fed on diet containing naked dsIAP, dsGFP, CS-dsIAP, CS-dsGFP, CS-TPP-dsIAP or CS-TPP-dsGFP
nanoparticles. Mortality was recorded on the 10th day after initiation of feeding. Mean ± S.E (n = 3). The
asterisks above the bar indicate the significance of difference (One-way ANOVA, Turkey’s test ***P< 0.001).

Figure 7. CS-TPP-AaIAP dsRNA nanoparticles trigger efficient knockdown of the AaIAP gene. Knockdown
of AaIAP gene was analyzed in mosquito larvae fed with naked dsIAP, CS-TPP-dsIAP or CS-TPP-dsGFP
nanoparticles by qRT-PCR. Five days after feeding naked dsIAP, dsGFP, CS-dsIAP, CS-dsGFP CS-TPP-dsIAP
or CS-TPP-dsGFP nanoparticles to Aedes aegypti larvae; the RNA was isolated, converted to cDNA and used in
qRT-PCR to determine relative IAP mRNA levels. Data are presented as mean ± SE. (n = 3). The asterisks above
the bar indicate the significance of difference (T-TEST, ***P< 0.001).
times with deionized water and resuspended in MilliQ ultrapure water. The nanoparticles were then sonicated for
5 min in an ultrasonic liquid processor and used for further analysis.

Gel retardation assay. The binding affinity of dsRNA to CS-TPP nanoparticles was confirmed by agarose
gel electrophoresis using a 1 kb plus DNA ladder for size reference. Naked dsRNA and CS-TPP nanoparticles were
used as positive and negative controls, respectively. The CS-TPP-dsRNA nanoparticles were loaded onto 1% agarose gels stained with GelRed (Biotium, USA). After electrophoresis, the gel was photographed with an Alpha
Imager Gel Imaging System (Alpha Innotech, San Leandro, CA) under ultraviolet light.

™

®

Dynamic light scattering (DLS) analysis. The mean particle size (Z-average), surface charge (Zeta potential)
and polydispersity (PDI) of CS-TPP-dsRNA nanoparticles were measured by photon correlation spectroscopy
(PCS) using Zetasizer (Malvern Instruments, UK). All measurements were made in triplicate at 25 °C and data
are reported as a mean ± standard deviation.

TEM imaging of CS-TPP-dsRNA nanoparticles. To determine the morphology of the nanoparticles, the
particles were viewed under a transmission electron microscope (TEM). A drop of CS-TPP-dsRNA nanoparticles
was fixed on a copper microgrid that was natively stained with 2% phosphotungstic acid. The stained nanoparticles were incubated for 10 min at room temperature. The nanoparticles were then viewed under a TEM (HRTEM,
JEOL 2010F, Japan) and images were captured.
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Determination of dsRNA loading efficiency. To determine the dsRNA loading efficacy of nanoparticles,
the dsRNA conjugated with nanoparticles was separated from free dsRNA by centrifugation. The free dsRNA in
the supernatants was measured by its absorbance at 260 nm wavelength using NanoDrop-2000 spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA). The amount of dsRNA incorporated within the nanoparticles
was calculated by the difference between the initial quantity of dsRNA (Total dsRNA) and the remaining amount
in the supernatant (Free dsRNA). The supernatant recovered from naked nanoparticles was used as a blank.
Entrapment efficiency was calculated using the following method53: Entrapment efficiency = Total dsRNA – Free
dsRNA/Total dsRNA x 100.
dsRNA stability assay. To investigate ex vivo degradation, an assay described recently was used54. Mosquito

larvae entire midgut was dissected and placed in 100 µl of 1X PBS and centrifuged for 10 min at 20,000 × g. The
supernatant was then collected and centrifuged in the same manner. Ten microliters of nanoparticles containing
1 µg of dsRNA were added to 10 µl (1 µg) of midgut extract and samples were collected at various time points (1, 3,
6, 12 and 24 h). Naked dsRNA was incubated in the midgut extract for 1 h as a control. The samples were resolved
on a 1.0% (w/v) agarose gel, stained with GelRed (Biotium, USA) and photographed with an Alpha Imager
Gel Imaging System (Alpha Innotech, San Leandro, CA) under ultraviolet light.

®

™

Storage stability of CS-TPP-dsRNA nanoparticle complexes. CS-TPP-dsRNA nanoparticles were
suspended in nuclease-free water and stored at 4 °C, 25 °C and 37 °C for 10 days. Nanoparticle stability was
determined by 1% agarose gel electrophoresis and nanoparticle size was measured at previously established time
points.
In vitro release studies.

The CS-TPP-dsRNA nanoparticles were incubated at room temperature (25 °C),
in 2 ml of 1x PBS at pH 7.4. At certain intervals, (10, 20, 30, 40, 50, and 60 h) nanoparticles were centrifuged
and 1.5 ml of the supernatant removed and replaced by 1x PBS solution. The amount of dsRNA released from
the nanoparticles was determined using the NanoDrop-2000 spectrophotometer (Thermo Fisher Scientific Inc.,
Waltham, MA).

Biodistribution of FITC labeled nanoparticles.

In vivo, biodistribution of nanoparticles was investigated using FITC-labeled nanoparticles. The FITC-labeled nanoparticles were prepared by following the method
described previously55. Five mosquito larvae were placed in each well of a 24-well plate containing 1 ml of
nuclease-free water. FITC-nanoparticles were evenly mixed with mosquito larval food and embedded in 1%
melted agarose. This food pellet was fed to mosquito larvae under dark conditions. After 24 h, the whole larvae were viewed under 4X magnification of fluorescence microscope (Nikon ECLIPSE 90i). For biodistribution
studies, mosquito larvae were dissected, and the alimentary canal and fat bodies attached to the epidermis were
collected and washed with 1X PBS. The tissues were visualized under 10X magnification of a fluorescence microscope (Nikon ECLIPSE 90i).

Cellular Internalization of nanoparticles by confocal microscopy. FITC labeled nanoparticles were
fed to the mosquito larvae, and at 24 h post feeding, the midgut and epidermis attached with fat body tissues
were dissected and washed with 1X PBS buffer. The tissues were fixed with 4% paraformaldehyde solution and
incubated at 4 °C overnight under dark conditions. The fixed tissues were mounted on microscope slides stained
with EverBrite mounting medium containing DAPI (Biotium, Inc. Fremont, CA) and examined under 63X
magnification in a confocal laser-scanning microscope (Leica TCS SP8) using DAPI, FITC (490–525 wavelength)
and bright field (BF) channels.

™

Mosquito rearing. Aedes aegypti (Waco strain) mosquitoes were reared as described previously27. Eggs were

collected from lab colony adults and stored dry for approximately 2–4 weeks before hatching. Eggs were hatched
in a 64 oz plastic pan containing 300 mL deoxygenated, filtered water inoculated with 10 mL of bovine live powder
feeding solution (60 g/L). The pans were maintained in an incubator at 27 ± 1.0 °C under a photoperiodic regime
of 16:8 hour (L: D). Freshly molted second-instar larvae were collected and briefly held in a separate pan containing filtered water before being transferred to 24-well plates for bioassays.

dsRNA synthesis. Nine candidate genes were selected based on previous studies of their efficacy as
RNAi triggers47,52,56,57. The dsRNA targeting these genes was in vitro synthesized using the MEGAscript T7
Transcription Kit (Ambion Inc., Foster City, CA USA) as described previously55. Briefly, 300–500 bp fragment of
each gene was PCR amplified using gene-specific primers (Table S4) containing T7 RNA polymerase sequence
at the 5′ end. 500 ng of the purified PCR product was used as a template in 20 μL in vitro transcription reaction.
The reactdsRNAion mix was incubated for 16 h at 37 °C, followed by 30 min of DNase I treatment. The reaction
mixture was heat inactivated at 70 °C for 10 min and cooled down slowly to room temperature. The dsRNA was
precipitated by adding 0.1x volume of sodium acetate (3 M, pH 5.2) and 2.5x volumes of 100% ethanol and then
kept at −20 °C for at least 2 h. The reaction contents were then centrifuged at 4 °C for 15 min. The dsRNA pellet
was rinsed with 75% ethanol and centrifuged again at 4 °C for 5 min. The ethanol was removed and the dsRNA
pellet was dried and resuspended in MilliQ ultrapure water. The quality and quantity of dsRNA were checked by
agarose gel electrophoresis and NanoDrop-2000 spectrophotometer (Thermo Fisher Scientific Inc., Waltham,
MA), respectively.
Mosquito feeding assay.

Mosquito larval food containing nanoparticles was prepared by following methods described previously20. Briefly, 50 µl of nanoparticles containing 40 µg of dsRNA were mixed with 5 mg of
bovine liver powder and added to 1.5% pre-melted agarose gel solution at 55 °C. A group of 5–7-second instar
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larvae were transferred to each well of 24-well plate containing 1 ml of deionized water. Each treatment was replicated three times, and each experiment was repeated at least five times. The food pellet containing 40 µg of dsRNA
was divided into three equal pieces and distributed to each well. Mortality was recorded until mosquito larvae in
the control group became adults. The transcript levels of the dsIAP target gene were determined on the 5th day
after the first feeding of dsRNA.

Quantitative Real-Time PCR (RT-qPCR). Total RNA was isolated from mosquito larvae using TRIzol
reagent (Molecular Research Center Inc., Cincinnati, OH) following the manufacturer’s protocol. The total RNA
was then treated with DNase I (Ambion Inc., Austin, TX). Two µg of total RNA was used for first strand cDNA
synthesized using M-MLV Reverse Transcriptase (Invitrogen, USA). The first strand cDNA was used as a template for qPCR analysis. Each 10 µl qRT-PCR (Applied Biosystems, USA) reaction contained 5 µl of Fast Start
SYBR Green Master mix (Roche Diagnostics, Indianapolis), 2 μl of 1:2 diluted cDNA and 0.2 μl each of 10 µM
forward and reversed gene-specific primers (Table S4). An initial incubation of 95o C for 3 min, followed by 40
cycles of 95 for 10 sec, 55 for 20 sec and 72 for 30 sec settings, were used. Each experiment was replicated a minimum of three times using the samples from independent treatments. Relative expression levels of a target gene
were determined using the reference gene, S7RP the 2−ΔΔCT method58.
Statistical analysis.

The nanoparticle characterization data (size, charge, and PDI) are shown as the
Mean ± STD. The statistical significance of gene expression analysis for qRT-PCR was determined using a t-test
analysis. A one-way analysis of variance (ANOVA) was used to determined larval mosquito mortality, and their
significance was compared by Turkey’s multiple comparison test. P values of <0.05 were considered significant.
The analyses were performed using GraphPad Prism 5 (La Jolla, CA) for windows.
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